NCT00562549View on ClinicalTrials.gov

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Hypertension
Interventions
DRUG

SLx-2101

Trial Locations (1)

CB2 2QQ

Addenbrooke's Hospital, Cambridge

Sponsors
All Listed Sponsors
lead

Response Pharmaceuticals

INDUSTRY

NCT00562549 - Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension | Biotech Hunter | Biotech Hunter